These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 2900602)

  • 1. An introduction to the pharmacologic properties of Dopacard (dopexamine hydrochloride).
    Smith GW; O'Connor SE
    Am J Cardiol; 1988 Aug; 62(5):9C-17C. PubMed ID: 2900602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Arrhythmogenic potential of dopexamine hydrochloride during halothane anaesthesia in dogs.
    Neustein SM; Dimich I; Sampson I; Sadeghi A; Mezrow C; Shiang H
    Can J Anaesth; 1994 Jun; 41(6):542-6. PubMed ID: 7915210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Dopexamine: a new dopaminergic agonist].
    Perrin G; Papazian L; Martin C
    Ann Fr Anesth Reanim; 1993; 12(3):308-20. PubMed ID: 7902685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The cardiovascular actions of dopexamine hydrochloride, an agonist at dopamine receptors and beta 2-adrenoceptors in the dog.
    Smith GW; Hall JC; Farmer JB; Simpson WT
    J Pharm Pharmacol; 1987 Aug; 39(8):636-41. PubMed ID: 2888855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relative significance of dopamine receptors, beta adrenoceptors and norepinephrine uptake inhibition in the cardiovascular actions of dopexamine hydrochloride.
    Goldberg LI; Bass AS
    Am J Cardiol; 1988 Aug; 62(5):37C-40C. PubMed ID: 2841837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in cardiovascular responsiveness to dopexamine and beta 1- and beta 2-adrenoceptor function after the chronic treatment of beta-adrenoceptor antagonists and agonists in anaesthetized dogs.
    Chang DH; Einstein R
    J Auton Pharmacol; 1996 Oct; 16(5):269-79. PubMed ID: 9023671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopexamine: a novel agonist at peripheral dopamine receptors and beta 2-adrenoceptors.
    Brown RA; Dixon J; Farmer JB; Hall JC; Humphries RG; Ince F; O'Connor SE; Simpson WT; Smith GW
    Br J Pharmacol; 1985 Jul; 85(3):599-608. PubMed ID: 2862944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the effects of dopexamine, a novel DA1 receptor and beta 2-adrenoceptor agonist, on cardiac function and splanchnic circulation in a canine model of hemorrhagic shock.
    Chintala MS; Moore RJ; Lokhandwala MF; Jandhyala BS
    Naunyn Schmiedebergs Arch Pharmacol; 1993 Mar; 347(3):296-300. PubMed ID: 8097568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dopexamine hydrochloride. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in acute cardiac insufficiency.
    Fitton A; Benfield P
    Drugs; 1990 Feb; 39(2):308-30. PubMed ID: 1970288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of dopexamine on the cardiovascular system of the dog.
    Brown RA; Farmer JB; Hall JC; Humphries RG; O'Connor SE; Smith GW
    Br J Pharmacol; 1985 Jul; 85(3):609-19. PubMed ID: 4027482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of chronic intravenous infusions of dopexamine and isoprenaline to rats on D1-, beta 1- and beta 2-receptor-mediated responses.
    Martin SW; Broadley KJ
    Br J Pharmacol; 1994 Jun; 112(2):595-603. PubMed ID: 7915614
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of dopexamine hydrochloride on calcium channels in isolated guinea pig ventricular myocytes.
    Dun W; Zhao RR; Liang Y; Wu BW
    Methods Find Exp Clin Pharmacol; 1996; 18(6):353-7. PubMed ID: 8892264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inotropic mechanisms of dopexamine hydrochloride in horses.
    Muir WW
    Am J Vet Res; 1992 Aug; 53(8):1343-6. PubMed ID: 1354950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contrasting effects of dopexamine hydrochloride on electrolyte excretion in canine kidney.
    Bass AS
    J Pharmacol Exp Ther; 1990 May; 253(2):798-802. PubMed ID: 1971021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of acute haemodynamic effects of dopexamine hydrochloride, dobutamine and sodium nitroprusside in chronic heart failure.
    Baumann G; Gutting M; Pfafferott C; Ningel K; Klein G
    Eur Heart J; 1988 May; 9(5):503-12. PubMed ID: 3402466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of Uptake1 by dopexamine hydrochloride in vitro.
    Mitchell PD; Smith GW; Wells E; West PA
    Br J Pharmacol; 1987 Oct; 92(2):265-70. PubMed ID: 2890392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of the beta 2 adrenoceptor in mediating positive inotropic activity in the failing heart and its relation to the hemodynamic actions of dopexamine hydrochloride.
    Lang RM; Borow KM; Neumann A; Carroll JD; Weinert L; Murphy MB; Ghali J; Rajfer SI
    Am J Cardiol; 1988 Aug; 62(5):46C-52C. PubMed ID: 2841838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies on the pharmacological interventions to prevent oxygen free radical (OFR)-mediated toxicity; effects of dopexamine, a DA1 receptor and beta 2 adrenoceptor agonist.
    Jacinto SM; Lokhandwala MF; Jandhyala BS
    Naunyn Schmiedebergs Arch Pharmacol; 1994 Sep; 350(3):277-83. PubMed ID: 7824044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Presynaptic effects of dopexamine hydrochloride in the canine kidney.
    Bass AS
    Naunyn Schmiedebergs Arch Pharmacol; 1992 Jan; 345(1):33-6. PubMed ID: 1347154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and mechanisms of dopexamine in the prevention of ischemia-reperfusion induced organ damage: role of oxygen free radicals.
    Jacinto SM; Chintala MS; Lokhandwala MF; Jandhyala BS
    Clin Exp Hypertens; 1997; 19(1-2):181-90. PubMed ID: 9028645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.